二维超声测量的心胸双顶径比在孕中期预测胎儿血红蛋白巴特病中的表现:一项先导研究
这项前瞻性诊断研究纳入孕17至22周有血红蛋白巴特病风险的胎儿,在脐带穿刺行血红蛋白分型前测量心胸双顶径比和心胸比。72例风险胎儿中31例确诊患病,心胸双顶径比以0.45为阈值时敏感度83.9%、特异度92.7%,心胸比以0.5为阈值时敏感度94.3%、特异度65.1%。作者认为心胸双顶径比是预测胎儿血红蛋白巴特病的新超声标志物,可能适用于α地中海贫血高流行、产前超声专家有限且产前诊断可及性差的地区。
要点
- 孕17至22周有血红蛋白巴特病风险的胎儿中,心胸双顶径比以0.45为阈值预测患病的敏感度83.9%、特异度92.7%。
- 心胸比以0.5为阈值预测患病的敏感度94.3%、特异度65.1%。
- 作者认为心胸双顶径比是预测胎儿血红蛋白巴特病的新超声标志物。
核心结论
- 心胸双顶径比是预测有风险胎儿血红蛋白巴特病的新超声标志物。
- 该标志物相对有效,可能适用于α地中海贫血高流行、产前超声专家有限且产前诊断可及性差的地区。
研究设计与样本
- 前瞻性诊断研究,纳入孕17至22周有血红蛋白巴特病风险的妊娠。
- 在脐带穿刺行血红蛋白分型前测量心胸双顶径比和心胸比,评估两者识别患病胎儿的表现。
- 共纳入72例有风险胎儿,其中31例确诊为血红蛋白巴特病。
主要发现
- 心胸双顶径比以0.45为阈值时,敏感度83.9%、特异度92.7%、阳性预测值89.7%、阴性预测值88.4%。
- 心胸比以0.5为阈值时,敏感度94.3%、特异度65.1%、阳性预测值68.8%、阴性预测值93.3%。
关键数值与推荐
- 心胸双顶径比阈值0.45:敏感度83.9%、特异度92.7%、阳性预测值89.7%、阴性预测值88.4%。
- 心胸比阈值0.5:敏感度94.3%、特异度65.1%、阳性预测值68.8%、阴性预测值93.3%。
临床怎么用
- 作者认为心胸双顶径比可能用于α地中海贫血高流行、产前超声专家有限且产前诊断可及性差地区的风险胎儿预测。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The aim of this study was to assess the performance of cardio-biparietal ratio measured by real-time two-dimensional ultrasound in predicting hemoglobin (Hb) Bart disease among fetuses at risk. METHOD: This prospective diagnostic study recruited pregnancies at risk for Hb Bart disease at 17 to 22 weeks' gestation. Cardio-biparietal ratio and cardiothoracic ratio were measured before cordocentesis for Hb typing. The performance of the cardio-biparietal ratio and cardiothoracic ratio for identifying affected fetuses was evaluated. RESULTS: Among 72 fetuses at risk, 31 were diagnosed as affected by Hb Bart disease. By using a cutoff 0.45, cardio-biparietal ratio had a sensitivity of 83.9%, specificity of 92.7%, positive predictive value of 89.7%, and negative predictive value of 88.4%, whereas cardiothoracic ratio using cutoff 0.5 had a sensitivity of 94.3%, specificity of 65.1%, positive predictive value of 68.8%, and negative predictive value of 93.3%. CONCLUSION: Cardio-biparietal ratio is a new sonomarker to predict Hb Bart disease among fetuses at risk. This sonomarker is relatively effective and may be useful in areas of high prevalence of alpha thalassemia disease, limited number of experts in prenatal ultrasound, and difficult access to prenatal diagnosis.
引用
- Traisrisilp K, Sirilert S, Tongsong T, et al. The performance of cardio-biparietal ratio measured by 2D ultrasound in predicting fetal hemoglobin Bart disease during midpregnancy: A pilot study. Prenat Diagn. 2019. PMID: 31087330. doi:10.1002/pd.5478
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。